Jacques Rossignol is a Managing Partner and Co-Founder of TechLife Capital.
He has been a private equity growth investor for more than 20 years, completing 11 investments and 14 build-ups. He has covered the healthcare industry for than 20 years and the technology industry for more than 25 years. Before TechLife Capital, he was head of France at Alpha Private Equity, Managing Partner at 21 Invest and Director at Ekkio.
Jacques is currently the President of the Supervisory Board of XPath Groupe (cancer diagnosis services), of Flash Therapeutics (manufacturer of lentiviral vectors for biotech companies), and of Mitem Pharma (pharmaceutical laboratory of drugs of major therapeutic interest), and a member of the Supervisory Board of Quinten (data science expert of AI-based solutions for pharma and healthcare services).
His previous Supervisory Board positions include Synerlab (manufacturer of pharmaceutical drugs) and Digital Virgo (mobile internet services).
He started his career in Investment Banking at BNP Paribas and Goldman Sachs (Paris, London).
Jacques is a graduate from Ecole Polytechnique and holds an MBA degree from the Harvard Business School.